Peptide record

TPDB92277

Gageostatin B Antibacterial Anticancer Antifungal Antiviral Toxicity modified_plain modified
7 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92277
Gageostatin B
Antibacterial Anticancer Antifungal Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0 dbACP CAFPdb dbAMP
modified_plain
Yes
A 7-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia, CancerPPD 2.0, dbACP, and other sources, with an available 3D structural model.
N-terminal: 3-beta-hydroxy-9,11-dimethyltridecanoic acid
Sequence
ELLVDLL
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
7 reviewed residue count
Free Activity
L Activity
Linear Activity
3-beta-hydroxy-9,11-dimethyltridecanoic acid Activity
Antimicrobial Activity
Bacillus subtilis Activity
Evidence Records 6 records
Evidence 1 Activity

Activity

GI50
GI50 = 16.1 µg/mL
Anticancer
16.1 µg/mL

Target

Breast Cancer
MDA-MB-231
Breast

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

GI50
GI50 = 18.3 µg/mL
Anticancer
18.3 µg/mL

Target

Colon Cancer
HCT-15
Colon

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014
Evidence 3 Activity

Activity

GI50
GI50 = 19.4 µg/mL
Anticancer
19.4 µg/mL

Target

Prostate Cancer
PC-3
Prostate

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014
Evidence 4 Activity

Activity

GI50
GI50 = 11.7 µg/mL
Anticancer
11.7 µg/mL

Target

Lung Cancer
NCI-H23
Lung

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014
Evidence 5 Activity

Activity

GI50
GI50 = 13.9 µg/mL
Anticancer
13.9 µg/mL

Target

Stomach Cancer
NUGC-3
Stomach

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014
Evidence 6 Activity

Activity

GI50
GI50 = 18.4 µg/mL
Anticancer
18.4 µg/mL

Target

Renal Cancer
ACHN
Kidney

Assay & Model

Sulforhodamine B assay
48-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2014